Trial Results Summaries

AstraZeneca takes an innovative approach to trial results summaries

25 Nov 2022

What Are Trial Results Summaries and Why Are They Necessary?

Trial Results Summaries

Trial results transparency starts here

25 Nov 2022

Trial Results Summaries provides an unbiased and non-promotional portal for sponsors to share trial results summaries, also known as plain language summaries (PLS), with participants and the public.

Citeline

2021 Completed Trials: Green Shoots of COVID-19 Recovery Become Apparent

27 Jun 2022

As the COVID-19 pandemic stretched through a second year, its impacts continued to reshape the clinical trials landscape.

Citeline Analytics

2017 Completed Clinical Trials: Status Quo or No Webinar Recording

By Laura Runkel 17 Jun 2022

For a deeper look into the data behind last year’s completed clinical trials and the trends driving them, Listen to the Completed Clinical Trials 2017: Status Quo or No?

TrialScope Disclose

CTIS Best Practices Whitepaper

16 Jun 2022

Europe’s new Clinical Trial Information System (CTIS), created by the European Medicines Agency (EMA), is due to be implemented in January 2022. Find out what sponsors must do to ensure compliance with this far-reaching new regulatory requirement.

Minimizing Luck in Study Feasibility Part 2

16 Jun 2022

Study feasibility is a fundamental contributor to the overall success of a clinical development program. However, selecting the right countries, sites and investigators and starting up as quickly as possible remains a challenge, leading to greatly variable performance and inaccurate predictions for important trial milestones.

TrialScope Disclose

Téléchargez votre livre blanc gratuit, « Compte à rebours du nouveau règlement européen sur les essais cliniques : à quoi s'attendre et comment se préparer »

11 Jan 2022

Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.

Informa Pharma Intelligence Partners with ICON to Launch an Integrated Predictive Analytic Solution for Clinical Trial Feasibility

13 Oct 2021

The companies will combine their extensive expertise and data sets to enhance Citeline Study Feasibility and help clinical trial teams accelerate the time to first and last patient in 

China Clinical Trials Landscape

28 Sep 2021

In 2017, Informa Pharma Intelligence took a deep dive into the clinical trial landscape in China over the previous 10 years, in a whitepaper entitled “Is China the Dark Horse in Clinical Development?”. That analysis showed that the number of trial starts in China had been trending upwards year-on-year and suggested that China was on course to become a formidable player within the pharma industry on a global stage.